Antioxidants Improve End Stage Cancer Survival
There remains controversy in the medical fields about the value of antioxidants, or risk of antioxidants in patients with cancer. In the Journal of International Medical research a pilot trial followed 41 patients over a 9 year period who had been diagnosed with end stage cancer. During this time they were given a mix of antioxidants including; Coenzyme Q10, vitamin C, selenium, folic acid and betacarotene.
The treatments were well tolerated and produced a > 40% increase in survival time with 76% of the patients surviving far longer than predicted. Whilst the study accounted for all participants and the disease course was well illustrated in all of the patients, there is a lack of retrospective design, matched controls and no blinding.
Read the rest of this page »
